Cargando…
Oral Administration of Branched-Chain Amino Acids Attenuates Atherosclerosis by Inhibiting the Inflammatory Response and Regulating the Gut Microbiota in ApoE-Deficient Mice
Atherosclerosis (AS) is a chronic inflammatory disease that serves as a common pathogenic underpinning for various cardiovascular diseases. Although high circulating branched-chain amino acid (BCAA) levels may represent a risk factor for AS, it is unclear whether dietary BCAA supplementation causes...
Autores principales: | Li, Ziyun, Zhang, Ranran, Mu, Hongna, Zhang, Wenduo, Zeng, Jie, Li, Hongxia, Wang, Siming, Zhao, Xianghui, Chen, Wenxiang, Dong, Jun, Yang, Ruiyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739883/ https://www.ncbi.nlm.nih.gov/pubmed/36501095 http://dx.doi.org/10.3390/nu14235065 |
Ejemplares similares
-
Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms
por: Zhang, Ranran, et al.
Publicado: (2022) -
Design, methods and baseline characteristics of the Beijing Hospital Atherosclerosis Study: a prospective dynamic cohort study
por: Zhang, Wenduo, et al.
Publicado: (2022) -
Association of serum glycine levels with metabolic syndrome in an elderly Chinese population
por: Li, Xianghui, et al.
Publicado: (2018) -
Association of Serum β-Hydroxybutyrate and Coronary Artery Disease in an Urban Chinese Population
por: Mu, Hongna, et al.
Publicado: (2022) -
Association of Branched-Chain Amino Acids with Carotid Intima-Media Thickness and Coronary Artery Disease Risk Factors
por: Yang, Ruiyue, et al.
Publicado: (2014)